MODERN ASPECTS OF BILATERAL BREAST CANCER. (LITERATURE REVIEW)

Authors

  • Javlon Abduraimovich Yuldashev
  • Mavluda Nematovna Karimova
  • Doniyar Anvarovich Pulatov

Keywords:

bilateral breast cancer, metachronous breast cancer, synchronous breast cancer, immunohistochemistry, unilateral breast cancer, multicentric breast cancer

Abstract

The lack of understanding of bilateral breast cancer is a much more complex problem for oncologists. Today the incidence of unilateral as well as bilateral breast cancer is much higher than 10 years ago, which makes this problem even more urgent. Information about the causes of bilateral breast cancer, important criteria for the development of the disease, early diagnosis of the disease and early detection of the possibility of bilateral metachronous cancer, as well as preventive measures are not fully covered in the literature, scientific studies. In this article, the authors analyze the data of the recommendations of the international scientific society and the results of large clinical trials on bilateral breast cancer. Also, important criteria in the development of metachronous and synchronous breast cancer were analyzed, the results of clinical and morphological, immunohistochemical aspects were studied. The reasons for the development and modern knowledge about the diagnosis of bilateral breast cancer have been studied. In particular, the authors reviewed and studied about 40 foreign and domestic scientific works devoted to this problem.

References

. Аблицова Н.В. Билатеральный синхронный рак молочной железы. Новое в терапии рака молочной железы / Н.В. Аблицова [и др.] // Онкология. -2014.-№ 1.-С. 14-18. (Ablitsova N.V. Bilateral synchronous breast cancer. New in the therapy of breast cancer / N.V. Ablitsova [et al.] // Oncology. -2014.-№ 1.-S. 14-18.)

. Бит-Сава Е.М. Генотип-фенотипические корреляции у больных раком молочной железы с мутациями BRCA1 (4153delA, 185delAG, 5382insC) / Е.М. Бит-Сава, В.Ф. Семиглазов, E.H. Имянитов // Опухоли женской репродуктивной системы. — 2014. — № 2. - С. 8-11. (Bit-Sava E.M. Genotype-phenotypic correlations in breast cancer patients with BRCA1 mutations (4153delA, 185delAG, 5382insC) / E.M. Bit-Sava, V.F. Semiglazov, E.H. Imyanitov // Tumors of the female reproductive system. - 2014. - No. 2. - S. 8-11.)

. Бобко Ю.И. Первично-множественный рак молочной железы / Ю.И. Бобко, С.Э. Савицкий // Онкологический журнал. - 2011. - Т. 5, № 3 (19). -С. 75. (Bobko Yu.I. Multiple primary breast cancer / Yu.I. Bobko, S.E. Savitsky // Journal of Oncology. - 2011. - T. 5, No. 3 (19). -FROM. 75.)

. Давыдов М.И. Статистика злокачественных новообразований в России и странах СНГ в 2009 г. / М.И. Давыдов, Е.М. Аксель // Вестник Российского онкологического научного центра им. H.H. Блохина РАМН. — 2010. -Т. 22 (3). — 172 с. (Davydov M.I. Statistics of malignant neoplasms in Russia and the CIS countries in 2009 / M.I. Davydov, E.M. Axel // Bulletin of the Russian Cancer Research Center. H.H. Blokhin Russian Academy of Medical Sciences. - 2010. -T. 22 (3). - 172 p.)

. Завалишина Л.Э. Исследование НЕЯ2/пеи-статуса рака молочной железы. Методические аспекты / Л.Э. Завалишина [и др.] // Архив патологии. — 2011.-JNbl.-C. 51-54. (Zavalishina L.E. Study of HER2 / pei-status of breast cancer. Methodical aspects / L.E. Zavalishina [et al.] // Archives of pathology. - 2011.-JNbl.-C. 51-54.)

. Завьялова М.В. Сравнение морфологического строения опухолевых узлов при билатеральном и одностороннем инвазивном протоковом раке молочных желез / М.В. Завьялова [и др.] // Сибирский онкологический журнал. - 2010. - Приложение № 1. - С. 46-47. (Zavyalova M.V. Comparison of the morphological structure of tumor nodes in bilateral and unilateral invasive ductal cancer of the mammary glands / M.V. Zavyalova [et al.] // Siberian Journal of Oncology. - 2010. - Appendix No. 1. - P. 46-47.)

. Каприн А.Д. Состояние онкологической помощи населению России в 2012 году / А.Д. Каприн, В.В. Старинский; под ред. Г.В. Петровой. - М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России, 2013. - 232 с. (Kaprin A.D. The state of cancer care to the population of Russia in 2012 / A.D. Kaprin, V.V. Starinsky; ed. G.V. Petrova. - M .: FGBU "MNIOI im. P.A. Herzen ”of the Ministry of Health of Russia, 2013. - 232 p.)

. Керимов P.A. Двусторонний рак молочных желез: особенности течения и результаты терапии / P.A. Керимов // Маммология. - 2005. - № 1. -С. 36-41. (Kerimov P.A. Bilateral breast cancer: features of the course and results of therapy / P.A. Kerimov // Mammology. - 2005. - No. 1. -S. 36-41.)

. Лепкова Н.В. Генетические аспекты метахронного рака молочной железы / Н.В. Лепкова [и др.] // Российский онкологический журнал. - 2008. -№ 2. - С. 4-8. (Lepkova N.V. Genetic aspects of metachronous breast cancer / N.V. Lepkova [et al.] // Russian Journal of Oncology. - 2008. -No. 2. - S. 4-8.)

. Нелюбина Л.А. Причины заболевания раком молочной железы и возможности его профилактики / Л.А. Нелюбина, К.П. Лактионов // Вестник РОНЦ им. Н.Н. Блохина РАМН. -2013. - № 2. - С. 3-10. (L.A. Nelyubina Causes of breast cancer and the possibility of its prevention / L.A. Nelyubina, K.P. Laktionov // Bulletin of the R. N.N. Blokhin Russian Academy of Medical Sciences. -2013. - No. 2. - P. 3-10.)

. Пак Д.Д. Первично-множественный рак молочной железы: обзор / Д.Д. Пак, Н.В. Аблицова // Российский онкологический журнал. - 2009. - № 4. -С. 48-52. (Pak D.D. Multiple primary breast cancer: a review / D.D. Pak, N.V. Ablitsova // Russian Journal of Oncology. - 2009. - No. 4. -S. 48-52.)

. Семиглазов В.Ф. Адыовантная эндокринотерапия гормон рецептор-положительного РМЖ / В.Ф. Семиглазов, А.Г. Манихас, В.В. Семиглазов // VIII международная ежегодная конференция «Проблемы диагностики и лечения рака молочной железы»: материалы конф. - М., 2011. - С. 117-133. (Semiglazov V.F. Adyovant endocrine therapy for hormone receptor-positive breast cancer / V.F. Semiglazov, A.G. Manikhas, V.V. Semiglazov // VIII international annual conference "Problems of diagnosis and treatment of breast cancer": materials of the conf. - M., 2011 .-- S. 117-133.)

. Сидоренко Ю.С. Проблемы первично-множественных процессов у больных раком молочной железы / Ю.С. Сидоренко [и др.] // Сибирский онкологический журнал. -2010. — № 1 (37).-С. 18-22. (Sidorenko Yu.S. Problems of primary multiple processes in patients with breast cancer / Yu.S. Sidorenko [et al.] // Siberian Journal of Oncology. -2010. - No. 1 (37) .- P. 18-22.)

. Тодоров С.С. Морфоиммуногистохимическая характеристика синхронного билатерального рака молочных желез / С.С. Тодоров [и др.] // Бюллетень экспериментальной биологии и медицины. - 2014. - № 5. - С. 663-666. (S. S. Todorov Morphoimmunohistochemical characteristics of synchronous bilateral breast cancer / S.S. Todorov [et al.] // Bulletin of Experimental Biology and Medicine. - 2014. - No. 5. - S. 663-666.)

. Фесик Е.А, Крахмаль Н.В, Завьялова М.В. Современные представления о билатеральном раке молочной железы. Бюллетень сибирской медицины 2014, том 13, № 15, С. 160-168. (Fesik E.A., Krakhmal N.V., Zavyalova M.V. Modern views on bilateral breast cancer. Bulletin of Siberian Medicine 2014, volume 13, No. 15, pp. 160-168.)

. Шведова М.В. Особенности строения первичного опухолевого узла при синхронном и метахронном билатеральном инвазивном протоковом раке молочных желез / М.В. Шведова [и др.] // Сибирский онкологический журнал. -2010. — Приложение № 1.-С. 115. (Shvedova M.V. Features of the structure of the primary tumor node in synchronous and metachronous bilateral invasive ductal cancer of the mammary glands / M.V. Shvedova [et al.] // Siberian Journal of Oncology. -2010. - Appendix No. 1.- С. 115.)

. Щедрин Д.Е. Билатеральный рак молочной железы (эпидемиологические аспекты) / Д.Е.Щедрин // Вопросы онкологии. - 2013. -№ 3. - С. 393-396. (D.E. Shchedrin Shchedrin D.E. Bilateral breast cancer (epidemiological aspects) // Problems of oncology. - 2013. -No. 3. - S. 393-396.)

. Abbott A. Perceptions of contralateral breast cancer: an overestimation of risk / A. Abbott [et al.] // Ann. Surg. Oncol. - 2011. - Vol. 18, № 11. - P. 3129-3136.

. Beckmann K.R. Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort / K.R. Beckmann [et al.] // Breast. -2011. — Vol. 20(2). -P. 158-164.

. Boyd N.F. Breast tissue composition and susceptibility to breast cancer / N.F. Boyd [et al.] //J. Natl. Cancer. Inst. -2010. -№ 102 (16). - P. 1224-1237.

. Eliassen A.H. Physical activity and risk of breast cancer among postmenopausal women / A.H. Eliassen [et al.] // Arch. Intern. Med. - 2010. -№ 170 (19).-P. 1758-1764.

. Figueiredo J. Oral Contraceptives and Post-menopausal Hormones and Risk of Contralateral Breast Cancer among BRCA1 and BRCA2 mutation carriers and non-carriers: The WECARE Study / J. Figueiredo [et al.] // Breast. Cancer. Res. and Treatment.-2010.-№ 120 (l).-P. 175-183.

. Graham A. Priorities for the primary prevention of breast cancer / A. Graham [et al.] // CA: A Cancer J. for Clinicians. - 2014. - Vol. 64(3). -P.186-194.

. Huo D. Concordance in histological and biological parameters between first and second primary breast cancers / D. Huo [et al.] // Cancer. - 2011. - Vol. 117. -P. 907-915.

. Irvine T. Prognosis of synchronous bilateral breast cancer / T. Irvine [et al.] // British. J. of Surgy. - 2009. - Vol. 96. - P. 376-380.

. Kabat G.C. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer / G.C. Kabat [et al.] // Cancer Causes Control. - 2010. -№ 21(6). - P. 821-828.

. Largent J.A. Reproductive history and risk of second primary breast cancer: the WECARE study / J.A. Largent [et al.] // Cancer Epidemiol. Biomarkers Prev. - 2007. - Vol. 16. - P. 906-911.

. Marchbanks P.A. Oral contraceptive formulation and risk of breast cancer / P.A. Marchbanks [et al.] // Contraception. - 2012. - № 85 (4). - P. 342-350.

. Narod S.A. Bilateral breast cancers / S.A. Narod // Nat. Rev. Clin. Oncol.-2014.-Vol. 11(3).-P. 157-166.

. Nelson H.D. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis / H.D. Nelson [et al.] // Ann. of Int. Med.-2012.-Vol. 156 (9).-P. 635-648.

. Phipps A.I. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population / A.I. Phipps [et al.] // Cancer Epidemiol. Biomarkers Prev. - 2010. - № 19.-P. 1643-1654.

. Poynter J.N. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study / J.N. Poynter [et al.] // Cancer Causes Control. -2010. - Vol. 21. - P. 839-846.

. Ritte R. Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study / R. Ritte [et al.] // Int. J. Cancer. - 2013. -№ 132 (11).-P. 2619-2629.

. Roder D. Survival From Synchronous Bilateral Breast Cancer: The Experience of Surgeons Participating in the Breast Audit of the Society of Breast Surgeons of Australia and New Zealand / D. Roder [et al.] // Asian Pacific J. of Cancer Prevention.-2012.-Vol. 13.-P. 1413-1418.

. Saltzman B.S. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral

breast cancer / B.S. Saltzman [et al.] // Breast Cancer Res. Treat. - 2012. - Vol. 135. -P. 849-855.

. Sandberg M.E. Diagnostic work-up of contralateral breast cancers has not improved over calendar period / M.E. Sandberg [et al.] // Breast Cancer Res. Treat.-2010.-Vol. 122.-P. 889-895.

. Schwentner L. Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients / L. Schwentner // Breast. - 2012. - № 21 (2). - P. 171.

. Senkus E. Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype / E. Senkus [et al.] // Int. J. Clin. Exp. Pathol. - 2014. -№ 7(1). - P. 353-363.

. Shi Y.X. Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer / Y.X. Shi [et al.] // J. Cancer Res. Clin. Oncol. - 2012. - Vol. 138. - P. 705-714.

. Tonelli M. Recommendations on screening for breast cancer in average-risk women aged 40-74 years / M. Tonelli [et al.] // CMAJ : Canadian Med. Association J.-2011.-№ 183(17).-P. 1991-2001.

. Wang T. The risk factors and prognosis of bilateral primary breast cancer: a comparative study with unilateral breast cancer / T. Wang [et al.] // Oncol. Res.-2011.-Vol. 19(3-4).-P. 171.

. Zavyalova M.V. The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis / M.V. Zavyalova [et al.] // Diagn. Cytopathol. - 2013. - № 41. - P. 279-282.

. Zendejas B. Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer / B. Zendejas [et al.] // J. Clin. Oncol. - 2011. - № 29. - P. 2993-3000.

. Zhou W.B. The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis / W.B. Zhou [et al.] // J. of Cancer Res. and Clin. Oncol. - 2011. - № 137(7). -P. 1053-1106.

Published

2021-02-26